Hopkins Michael M, Ibanez Fabien, Skingle Malcolm
University of Sussex Business School, Brighton, UK.
GlaxoSmithKline, institution city, institution country.
Future Healthc J. 2021 Jul;8(2):e210-e217. doi: 10.7861/fhj.2021-0091.
A wide range of stakeholders recognise that physicians play a vital role in medical innovation and, in particular, the importance of boundary-spanning engagement between physicians and industry in clinical research. While UK physicians are keen to take part in research, this article draws on a range of literature to identify apparent and anticipated challenges that discourage or prevent cross-sector engagement by physician researchers. To encourage greater interaction and exploration of associated support mechanisms, we present a full spectrum of engagement modes, funding opportunities and illustrative initiatives, showing how different stakeholders (from government institutions, charities, professional bodies and industry) can contribute to improving the engagement of physicians in boundary spanning research. We emphasise the importance of mutual understanding, trust and commonly shared practices, as well as adequate resources, to encourage these vital interactions.
众多利益相关者认识到医生在医学创新中发挥着至关重要的作用，尤其是医生与行业在临床研究中的跨界合作的重要性。虽然英国医生热衷于参与研究，但本文借鉴了一系列文献，以识别阻碍或阻止医生研究人员进行跨部门合作的明显和预期挑战。为了鼓励更多的互动和探索相关支持机制，我们展示了全方位的合作模式、资金机会和示例举措，展示了不同利益相关者（来自政府机构、慈善机构、专业团体和行业）如何为提高医生参与跨界研究做出贡献。我们强调相互理解、信任和共同的实践以及充足资源对于鼓励这些重要互动的重要性。
